FIELD: microbiology; medicine.
SUBSTANCE: invention relates to microbiology and medicine. Agent for restoring the normal autochthonous microflora of the subject contains an active component containing microorganisms derived from the proprietary microflora of said subject or obtained from the microflora of a donor selected from the group including the mother and other maternal relatives, said microorganisms including bacteriophages.
EFFECT: prevention and treatment of diseases and conditions associated with the violation of normal (autochthonous) microflora (microbiota) of humans or animals.
30 cl, 14 ex, 12 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| EXTRACELLULAR DNA AS A THERAPEUTIC TARGET IN NEURODEGENERATION | 2016 |
|
RU2726131C2 |
| FRACTIONATED ANTIMICROBIAL COMPOSITIONS AND THEIR USE | 2018 |
|
RU2795891C2 |
| DRUG FOR TREATMENT OF DISEASES CAUSED BY BACTERIA | 2020 |
|
RU2754610C1 |
| METHOD FOR DETERMINING MICROORGANISM SENSITIVITY TO ANTIMICROBIAL SUBSTANCES | 2012 |
|
RU2505813C1 |
| TREATMENT OF DISEASES BY MEANS OF EXPRESSION OF ENZYME WITH DEOXYRIBONUCLEASE (DNase) ACTIVITY IN LIVER | 2019 |
|
RU2773691C2 |
| FUNGICIDAL AGENT | 2010 |
|
RU2448960C1 |
| METHOD FOR ENDOGENOUS INTERFERON INDUCTION | 2010 |
|
RU2427373C1 |
| METHOD OF OBTAINING BIOCIDAL POLYGUANIDINE AND BIOCIDAL POLYGUANIDINE | 2009 |
|
RU2422137C1 |
| METHOD FOR TREATING HUMAN DISEASES ACCOMPANIED WITH INCREASED DNA CONTENT IN EXTRACELLULAR SPACES OF TISSUES AND MEDICINAL PREPARATION FOR ITS REALIZATION | 2005 |
|
RU2308968C2 |
| METHOD FOR RESTORING ONE'S OWN INTESTINAL MICROBIOTA AFTER ANTIBIOTIC THERAPY | 2021 |
|
RU2775887C1 |
